The partners aim to develop AI-powered, real-time, personalized brain-computer interface therapies for neurological disorders ...

InBrain Neuroelectronics announced today that it entered into a strategic collaboration with Microsoft to explore AI in ...

A New York-based biotech firm announced it has raised an additional $200 million in financing to advance commercialization of ...

Inbrain will apply Microsoft's agentic AI and cloud tech to its brain-computer interface, which could facilitate faster ...

The funds are expected to accelerate commercialization of the company’s Stentrode BCI platform, while advancing development ...

Synchron Funding will advance commercialization of the Stentrode™ BCI platform and expand AI and engineering operations in New York and San Diego The round was led by Double Point Ventures, alongside ...

Inbrain Neuroelectronics signed a pact with Microsoft to use the tech giant’s Azure AI infrastructure to advance the Spanish ...

Viewed as the next evolution of artificial intelligence (AI), agentic AI enables systems to act autonomously based on ...

The company will use the funds to expand its in-house operations in New York and San Diego, as well as accelerate the trials ...

Electrodes play a pivotal role in neural implants, including BCI. Electrodes are small pads and wires attached to the chest, ...

The growing adoption of BCI technology is attributable to its rising awareness in treating a wide range of brain disorders. The growing incidences of brain disorders, stroke, depression, and Parkinson ...

Brain-computer interface (BCI) technology creates a direct link between the brain’s electrical activity and a digital device. This connection can bring a vast range of benefits in assisting, ...